Anna Holm participates in the development of communication plans, writes for web and newsletters, develops communication materials, and supports researchers in everything from poster production to drafting press releases, evaluating and reporting communication efforts. She supports communication and dissemination in the H2020 projects SIENNA and STARBIOS2, and in the IMI funded PREFER: patient preferences project.
Anna Holm has a bachelor’s degree in media and communication science from Linköping University and another in languages from Uppsala University.
Follow Anna Holm on Twitter.
Phone: +46 18 471 62 22
Giving patients a voice in drug development
PREFER is a five year public-private research project where academic researchers and the pharmaceutical industry work together to find out when and where patients want, can and should be involved in drug development
Responsible Research and Innovation (RRI)
Promoting organisational change in 6 bioscience institutions.
Technology, ethics and human rights
Genomics, Enhancement, AI & Robotics
The SIENNA project will address ethical issues in three new and emerging areas with major socio-economic impact.
MIND THE RISK · DEN GENETISKA RISKINFORMATIONENS ETIK FÖR INDIVID OCH SAMHÄLLE: SLUTRAPPORT FRÅN ETT FORSKNINGSPROGRAM
Makadam Förlag, 2019.